Publications by authors named "Heather W Dolby"
We systematically evaluated randomized-controlled trials (RCTs) for Staphylococcus aureus bacteremia (SAB). There was intertrial heterogeneity in cohort characteristics, including bacteremia source, complicated SAB, and comorbidities. Reporting of cohort characteristics was itself variable, including bacteremia source and illness severity.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to evaluate the long-term effectiveness and safety of the adalimumab biosimilar SB5 in patients with inflammatory bowel disease (IBD), comparing those who switched from the ADA originator and those who started directly on SB5.
- A total of 481 IBD patients were analyzed, with 70.8% of those who switched to SB5 remaining on the treatment after a year, while 60.3% of new users also persisted beyond that timeframe.
- Overall, no significant changes in clinical outcomes were observed post-switch, suggesting that switching to SB5 is both effective and safe for long-term use in IBD patients.
Article Synopsis
- - The study investigates the occurrence of pulmonary microthrombosis and vasculitis in fatal cases of COVID-19 and compares it to other serious respiratory virus infections.
- - Autopsy studies from various viruses, including influenza and SARS, were analyzed, revealing significant findings related to blood clots (thrombosis) in these cases.
- - Histological analysis showed that adults who died from influenza and SARS often exhibited evidence of thrombosis and some cases of vasculitis.